We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Post-tuberculosis treatment paradoxical reactions

    Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation...

    Sabine M. Hermans, Onno W. Akkerman, ... Martin P. Grobusch in Infection
    Article Open access 02 July 2024
  2. Anti-tuberculosis drug-induced acute liver failure requiring transplantation in the second trimester of pregnancy: a case report

    Background

    Treatment of tuberculosis (TB) during pregnancy can reduce maternal and foetal complications. However, it may also induce fatal liver...

    Zhoufeng Zhu, Min Zhang, Yang Li in BMC Pregnancy and Childbirth
    Article Open access 31 August 2021
  3. Talaromyces marneffei and Mycobacterium tuberculosis co-infection in a patient with high titer anti-interferon-Îł autoantibodies: a case report

    Background

    High-titer anti-interferon (IFN)-Îł autoantibodies are strongly associated with intracellular pathogens such as nontuberculous mycobacteria...

    Ye Qiu, Mianluan Pan, ... Jianquan Zhang in BMC Infectious Diseases
    Article Open access 28 January 2022
  4. Relationship of neutrophil lymphocyte ratio, monocyte lymphocyte ratio and neutrophil monocyte ratio with treatment response in pulmonary tuberculosis patients during intensive phase treatment

    Objective

    To determine the relationship of Neutrophil Lymphocyte Ratio (NLR), Monocyte Lymphocyte Ratio (MLR), and Neutrophil Monocyte Ratio (NMR)...

    Muniza Omair, Mirza Saifullah Baig, ... Mehreen Mehmood in BMC Infectious Diseases
    Article Open access 21 June 2024
  5. Esophageal anthracosis occurred after treatment of esophageal tuberculosis secondary to mediastinal tuberculous lymphadenitis: a rare case report

    Background

    Anthracosis is a disease generally considered to be in the lungs resulting from exposure to industrial dust in the workplace. Esophageal...

    Weixin Cheng, **nxin Zhou, ... Feng Ji in BMC Infectious Diseases
    Article Open access 21 March 2023
  6. A case report of persistent drug-sensitive pulmonary tuberculosis after treatment completion

    Background

    Mycobacterium tuberculosis (Mtb) has been found to persist within cavities in patients who have completed their anti-tuberculosis therapy....

    Sergo A. Vashakidze, Abivarma Chandrakumaran, ... Russell R. Kempker in BMC Infectious Diseases
    Article Open access 19 November 2022
  7. [18F]FDG PET and CT findings at therapy completion of pulmonary tuberculosis: comparison between HIV-positive and HIV-negative patients and impact on treatment response assessment

    Background

    [ 18 F]FDG-PET/CT is a sensitive non-invasive tool for assessing treatment response in patients with pulmonary tuberculosis. The data on the...

    Aisha Ismaila, Ismaheel O. Lawal, ... Mike Machaba Sathekge in Clinical and Translational Imaging
    Article Open access 24 May 2024
  8. Urokinase in the treatment of tuberculous pleurisy: a systematic review and meta-analysis

    Objective

    To evaluate the efficacy of urokinase (UK) treatment for tuberculous pleural effusion (TPE).

    Methods

    We searched Chinese biomedical...

    Wenyao **g, Ruolan Weng, ... Miao Luo in BMC Infectious Diseases
    Article Open access 24 February 2024
  9. Ganglionar tuberculosis infection evolving to hemophagocytic lymphohistiocytosis after anti-programmed cell death 1 treatment for high-risk melanoma: a case report

    Background

    Hemophagocytic lymphohistiocytosis is a rare, potentially fatal syndrome of immune hyperactivation. Here we describe a ganglionar...

    Cesar M. Costa, Luiza L. Gadotti, ... Rodrigo R. Munhoz in Journal of Medical Case Reports
    Article Open access 08 July 2021
  10. Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients

    Background

    Mycobacterium (M.) tuberculosis -caused immunopathology is characterized by aberrant expression of plasma cytokines in human tuberculosis....

    Monika M. Vivekanandan, Ernest Adankwah, ... Marc Jacobsen in Infection
    Article Open access 27 June 2022
  11. Combined Retrospective-Prospective Cohort Study to Know the Risk of Sensorineural Hearing Loss in Patients of Drug Resistant TB Receiving Anti Tuberculous Treatment (ATT) at Tertiary Care Centre in South Gujarat

    Combined retrospective—prospective cohort study was done to know the risk of sensorineural hearing loss in patients of drug resistant Tuberculosis...

    Khushi N. Bhavsar, Anandkumar V. Chaudhari, ... Hiteshri C. Patel in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 15 June 2023
  12. Anti-tuberculosis drugs

    Article 23 January 2021
  13. Predictors of tuberculosis infection among adults visiting anti-retroviral treatment center at east and west Gojjam, northwest, Ethiopia, 2017

    Background

    Tuberculosis is a serious health risk, for people living with human immune deficiency virus worldwide, and the burden of TB/HIV infection...

    Habtamu Belew, Moges Wubie, ... Tesfa Birlew in BMC Infectious Diseases
    Article Open access 12 August 2020
  14. The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis

    Background

    The potential role of adjunctive anti-inflammatory therapy to enhance tuberculosis (TB) treatment has recently received increasing...

    Frank Ekow Atta Hayford, Robin Claire Dolman, ... Cristian Ricci in Respiratory Research
    Article Open access 26 August 2020
  15. Safety of secukinumab in the treatment of patients with axial spondyloarthritis and concurrent hepatitis B virus infection or latent tuberculosis infection

    Objective

    To evaluate the safety of secukinumab (SEC) in the treatment of patients with axial spondyloarthritis (axSpA) and concurrent hepatitis B...

    Suling Liu, Ziye He, ... Yang Cui in Clinical Rheumatology
    Article 23 May 2023
  16. Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation

    Background

    Rifampicin-resistant tuberculosis (RR-TB) treatment requires combination treatment, which frequently causes serious adverse events and...

    Mahamadou Bassirou Souleymane, Tom Decroo, ... Alberto Piubello in Trials
    Article Open access 13 December 2022
  17. Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review

    Background and Objective

    Quantifying exposure to drugs for personalized dose adjustment is of critical importance in patients with tuberculosis who...

    Prakruti S. Rao, Nisha Modi, ... Jan-Willem C. Alffenaar in Clinical Pharmacokinetics
    Article Open access 04 March 2023
  18. Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial

    Background

    Tuberculous meningitis (TBM) is the most lethal and disabling form of tuberculosis (TB), particularly in sub-Saharan Africa. Current...

    Thomas Maitre, Maryline Bonnet, ... Fabrice Bonnet in Trials
    Article Open access 08 November 2022
  19. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis

    Background

    Both tuberculosis (TB) and diabetes mellitus (DM) are major public health problems threatening global health. TB patients with DM have a...

    Guisheng Xu, **aojiang Hu, ... **uting Li in BMC Infectious Diseases
    Article Open access 20 November 2023
  20. Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature Review

    Introduction

    Acute kidney injury (AKI) is occasionally detected in patients receiving anti-tuberculosis (TB) treatment. This prospective cohort study...

    Chia-Hao Chang, Lih-Yu Chang, ... Chong-Jen Yu in Infectious Diseases and Therapy
    Article Open access 11 February 2023
Did you find what you were looking for? Share feedback.